Anti-cancer therapy is associated with long-term epigenomic changes in childhood cancer survivors.
Robinson N, Casement J, Gunter MJ, Huybrechts I, Agudo A, Barranco MR, Eichelmann F, Johnson T, Kaaks R, Pala V, Panico S, Sandanger TM, Schultze MB, Travis RC, Tumino R, Vineis P, Weiderpass E, Skinner R, Sharp L, McKay JA, Strathdee G.
Robinson N, et al. Among authors: sharp l.
Br J Cancer. 2022 Jul;127(2):288-300. doi: 10.1038/s41416-022-01792-9. Epub 2022 Mar 30.
Br J Cancer. 2022.
PMID: 35354948
Free PMC article.
We investigated the hypothesis that anti-cancer treatments are associated with long-term DNA methylation changes that could be key drivers of adverse late health effects. ...CONCLUSIONS: These novel methylation changes could serve as biomarkers for assessing normal cell to …
We investigated the hypothesis that anti-cancer treatments are associated with long-term DNA methylation changes that could be key dr …